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Enzymes in the α-D-phosphohexomutases superfamily frequently play a role in the 
biosynthesis of carbohydrates and glycolipids, critical for bacterial virulence and growth. 
α-D-phosphohexomutases are being increasingly shown to play key roles in microbial 
infections, including enzymes from several major human pathogens. Successful 
inhibition of enzymes in the  
α-D-phosphohexomutases superfamily may result in decreased bacterial growth rates, 
decreased virulence and greater susceptibility to traditional antibiotic treatment. As an 
initial step toward inhibitor design, we are conducting fragment-based screens of two 
structurally characterized members of the enzyme superfamily: P. aeruginosa 
phosphomannomutase/ phosphoglucomutase (PMM/PGM) and S. typhimurium 
phosphoglucomutase (PGM). Fragment based screening is a relatively new method that 
has been effectively used in the design of drug-like inhibitors for many systems. 
Crystals of PMM/PGM and PGM have been soaked with cocktails of small molecules 
(typical molecular weight 100-300 Da) to determine their sites of interaction with the 
proteins. X-ray diffraction data will be collected on these soaked crystals and the 
binding sites analyzed to determine the optimal interactions for effective inhibition. 
